Pathogenic DDX41 variants, possible response predictors to low-dose melphalan in hypo- and normocellular MDS and AML.
Nyquist OE, Dalgaard J, Spetalen S, Torkildsen S, Frøen H, Galteland E, Klungsøyr O, Bergrem A, Vo C, Sørbø H, Eiken B, Lerdal H, Solvang AK, Jensvoll H, Pandzic T, Baliakas P, Dybedal I.
Nyquist OE, et al. Among authors: bergrem a.
Br J Haematol. 2024 Feb;204(2):724-729. doi: 10.1111/bjh.19226. Epub 2023 Nov 28.
Br J Haematol. 2024.
PMID: 38016923
No abstract available.